HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jaquelyn A Hank Selected Research

lorukafusp alfa

10/2019Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jaquelyn A Hank Research Topics

Disease

1Neoplasms (Cancer)
01/2020
1Neuroblastoma
10/2019
1Residual Neoplasm
10/2019
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2011

Drug/Important Bio-Agent (IBA)

2Interleukin-2 (IL2)IBA
10/2019 - 09/2011
1Biomarkers (Surrogate Marker)IBA
01/2020
1Immunoglobulin G (IgG)IBA
01/2020
1Neoplasm AntibodiesIBA
01/2020
1lorukafusp alfaIBA
10/2019
1CytokinesIBA
10/2019
1Isotretinoin (Accutane)FDA LinkGeneric
10/2019
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
10/2019
1Interleukin-2 Receptors (IL 2 Receptor)IBA
09/2011

Therapy/Procedure

2Therapeutics
10/2019 - 09/2011